151 related articles for article (PubMed ID: 7340458)
1. Platelet thromboxane production during endotoxin shock.
Prancan A; Simon D; Pope L
Agents Actions; 1981 Dec; 11(6-7):648-50. PubMed ID: 7340458
[TBL] [Abstract][Full Text] [Related]
2. Effect of endotoxin on arachidonic acid release and thromboxane B2 production by human platelets.
Stuart MJ
Am J Hematol; 1981 Sep; 11(2):159-64. PubMed ID: 7030066
[TBL] [Abstract][Full Text] [Related]
3. Changes in thromboxane formation by platelets during and after a continuous endotoxin infusion into rabbits.
Ditter H; Matthias FR
Vasa; 1984; 13(4):327-32. PubMed ID: 6516562
[No Abstract] [Full Text] [Related]
4. RCS from human platelets: is it only thromboxane?
Smith EF; Rücker W; Schrör K
Eur J Pharmacol; 1983 Nov; 95(1-2):121-4. PubMed ID: 6667711
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of coronary circulatory failure and thromboxane A2 release during coronary occlusion and reperfusion by 2-phenylaminoadenosine (CV-1808) in anesthetized dogs.
Tanabe M; Terashita Z; Nishikawa K; Hirata M
J Cardiovasc Pharmacol; 1984; 6(3):442-8. PubMed ID: 6202970
[TBL] [Abstract][Full Text] [Related]
6. Exchange transfusions in rats with a perfluorated blood substitute: effect on thromboxane B2 levels during endotoxemia.
Cook JA; Wise WC; Tempel GE; Halushka PV
Circ Shock; 1985; 15(3):193-204. PubMed ID: 3978769
[TBL] [Abstract][Full Text] [Related]
7. Fish oil fatty acids and human platelets: dose-dependent decrease in dienoic and increase in trienoic thromboxane generation.
Krämer HJ; Stevens J; Grimminger F; Seeger W
Biochem Pharmacol; 1996 Oct; 52(8):1211-7. PubMed ID: 8937428
[TBL] [Abstract][Full Text] [Related]
8. Protective effects of thromboxane A2 synthetase inhibitors on endotoxin shock.
Fukumoto S; Tanaka K
Prostaglandins Leukot Med; 1983 Jun; 11(2):179-88. PubMed ID: 6576388
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of thromboxane A2 synthesis in human platelets by coagulation factor Xa.
Sinha AK; Rao AK; Willis J; Colman RW
Proc Natl Acad Sci U S A; 1983 Oct; 80(19):6086-90. PubMed ID: 6577468
[TBL] [Abstract][Full Text] [Related]
10. Thromboxane A2 and hemodynamic-biochemical parameters in canine endotoxin shock.
Sakanishi N; Tsunoda Y; Takekawa K; Ikezono E
Bull Tokyo Med Dent Univ; 1983 Jun; 30(2):37-46. PubMed ID: 6580966
[TBL] [Abstract][Full Text] [Related]
11. HA-29: an inhibitor of thromboxane A2 formation with antagonism of thromboxane A2/prostaglandin endoperoxide receptor in rabbit platelets.
Lin CH; Kuo SC; Huang LJ; Huang TF; Teng CM
Thromb Res; 1992 Apr; 66(1):61-73. PubMed ID: 1412184
[TBL] [Abstract][Full Text] [Related]
12. Elevated thromboxane levels in the rat during endotoxic shock: protective effects of imidazole, 13-azaprostanoic acid, or essential fatty acid deficiency.
Cook JA; Wise WC; Halushka PV
J Clin Invest; 1980 Jan; 65(1):227-30. PubMed ID: 7350199
[TBL] [Abstract][Full Text] [Related]
13. Implications for thromboxane A2 in the pathogenesis of endotoxic shock.
Wise WC; Cook JA; Halushka PV
Adv Shock Res; 1981; 6():83-91. PubMed ID: 6961767
[TBL] [Abstract][Full Text] [Related]
14. Do prostacyclin and thromboxane play a role in endotoxic shock?
Webb PJ; Westwick J; Scully MF; Zahavi J; Kakkar VV
Br J Surg; 1981 Oct; 68(10):720-4. PubMed ID: 7025959
[TBL] [Abstract][Full Text] [Related]
15. In vitro effects of synthetic antioxidants and vitamin E on arachidonic acid metabolism and thromboxane formation in human platelets and on platelet aggregation.
Agradi E; Petroni A; Socini A; Galli C
Prostaglandins; 1981 Aug; 22(2):255-66. PubMed ID: 6794104
[TBL] [Abstract][Full Text] [Related]
16. Plasma thromboxane concentrations are raised in patients dying with septic shock.
Reines HD; Halushka PV; Cook JA; Wise WC; Rambo W
Lancet; 1982 Jul; 2(8291):174-5. PubMed ID: 6123885
[TBL] [Abstract][Full Text] [Related]
17. Influence of selective thromboxane synthetase blocker CGS-13080 on thromboxane and prostacyclin biosynthesis in whole blood: evidence for synthesis of prostacyclin by leukocytes from platelet-derived endoperoxides.
Mehta J; Mehta P; Lawson DL; Ostrowski N; Brigmon L
J Lab Clin Med; 1985 Sep; 106(3):246-52. PubMed ID: 3928780
[TBL] [Abstract][Full Text] [Related]
18. Increased platelet thromboxane synthesis in diabetes mellitus.
Halushka PV; Rogers RC; Loadholt CB; Colwell JA
J Lab Clin Med; 1981 Jan; 97(1):87-96. PubMed ID: 7452084
[TBL] [Abstract][Full Text] [Related]
19. 5-Hydroxytryptamine and thromboxane in platelets from rats treated with monocrotaline pyrrole.
Ganey PE; Roth RA
Toxicol Appl Pharmacol; 1987 Apr; 88(2):157-64. PubMed ID: 3564035
[TBL] [Abstract][Full Text] [Related]
20. [Protein binding of thromboxane--one of the sources of error in thromboxane determination].
Wirthumer-Hoche C; Sinzinger H
Wien Klin Wochenschr; 1985 Mar; 97(6):282-5. PubMed ID: 3993037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
